Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

A new international cooperation study indicates that in the future pancreatic cancer may be detected at an early stage from gut microbes. Gut microbes may also offer solutions for therapy development.

The composition of the gut microbiome appears to be associated with treatment response in patients with pancreatic cancer, research suggests.

Breakthrough vaccine targets pancreatic cancer cells, showing promise in preclinical trials and paving the way for human testing.

Daraxonrasib gains FDA breakthrough therapy status for treating metastatic pancreatic cancer with KRAS G12X mutations, ...

Experts hope the test will enable doctors to pick up early signs of the deadly disease, which can have vague or no symptoms.

Intraductal papillary mucinous tumor (IPMT) of the pancreas has been described as an intraductal pancreatic tumor formed from papillary proliferations of mucin-producing epithelial cells that have ...

Pancreatic cancer vaccines eliminate disease in preclinical studies Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer ...

The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.

Your brain makes insulin—the same insulin produced by your pancreas. The same insulin that is not produced in people with type 1 diabetes and the same insulin that does not work properly in ...